NPHP4 p.Arg1054His
c.3161G>A · rs369950850 · VCV578586
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2054 | likely benign |
|---|---|---|
| REVEL | 0.73 | pathogenic-leaning |
| SaProt | LLR -8.58 | tolerated |
| ⇒ REVEL calls this damaging; AlphaMissense and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.5 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 1.02 | unconstrained · MANE · 123 kb · p 0.49 · regional, not allelic |
| Overall | ||
| CADD | 29.8 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0643% | 1,555 |
| Finnishnot grpmax-eligible | 0.0513% | 1,951 |
| East Asian | 0.0407% | 2,456 |
| Admixed American | 0.0395% | 2,530 |
| South Asian | 0.0249% | 4,011 |
| Middle Eastern | 0.0166% | 6,024 |
| Remaining individualsnot grpmax-eligible | 0.0145% | 6,878 |
| European (non-Finnish) | 0.00673% | 14,857 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- NPHP4
- Protein
- p.Arg1054His
- Coding
- c.3161G>A
- MANE Select
- NM_015102
- dbSNP
- rs369950850
- Type
- single nucleotide variant
- Location
- chr1:5874541 (GRCh38)
- Gene constraint
- LOEUF 1.183 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 72.44
- Residue 1054
- the 'sufficient for basal bodies localization' region
Disease context
nephronophthisis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: nephronophthisis 4Senior-Loken syndrome 4
For Nephronophthisis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Antenatal, Childhood, Infancy, Neonatal
- Prevalence
- 1-9 / 100 000 (Finland)
Similar variants
- NPHP4 p.Arg1054Cys Conflicting classifications of pathogenicity ★ ⚠ same residue
- NPHP4 c.2304+1G>A Pathogenic ★★ same condition
- NPHP4 c.2611+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NPHP4 c.2611+1G>C Pathogenic ★★ same condition
- NPHP4 c.3644+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NPHP4 c.3644+1G>T Pathogenic/Likely pathogenic ★★ same condition
- NPHP4 c.517+1G>A Pathogenic/Likely pathogenic ★★ same condition
- NPHP4 c.518-2A>G Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/nphp4-p-arg1054his (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown